Publicacions en col·laboració amb investigadors/es de Centro de Investigación Médica Aplicada (8)

2019

  1. The cirrhotic liver is depleted of docosahexaenoic acid (DHA), a key modulator of NF-κB and TGFβ pathways in hepatic stellate cells

    Cell Death and Disease, Vol. 10, Núm. 1

2016

  1. Insulin-like growth factor I (IGF-I) expressed from an AAV1 vector leads to a complete reversion of liver cirrhosis in rats

    PLoS ONE, Vol. 11, Núm. 9

  2. Long noncoding RNA EGOT negatively affects the antiviral response and favors HCV replication

    EMBO Reports, Vol. 17, Núm. 7, pp. 1013-1028

2015

  1. Mesenchymal stromal cells engineered to produce IGF-I by recombinant adenovirus ameliorate liver fibrosis in mice

    Stem Cells and Development, Vol. 24, Núm. 6, pp. 791-801

  2. Transient depletion of specific immune cell populations to improve adenovirus-mediated transgene expression in the liver

    Liver International, Vol. 35, Núm. 4, pp. 1274-1289

2014

  1. Targeting the insulin-like growth factor pathway in hepatocellular carcinoma

    World Journal of Hepatology, Vol. 6, Núm. 10, pp. 716-737

2012

  1. AAV vectors transduce hepatocytes in vivo as efficiently in cirrhotic as in healthy rat livers

    Gene Therapy, Vol. 19, Núm. 4, pp. 411-417

2008

  1. Semi-mechanistic description of the in-vitro antiproliferative effect of different antitumour agents

    Journal of Pharmacy and Pharmacology, Vol. 60, Núm. 1, pp. 77-82